NCCN 2026 Annual Conference: In-Person Attendance

March 27, 2026 to March 29, 2026

The NCCN 2026 Annual Conference is designed to address timely and important educational needs of cancer care providers to improve and facilitate quality, effective, equitable and accessible cancer care so patients can live better lives.

The conference focuses on the practical management of patients living with or at risk for cancer, provides updates of NCCN Guidelines®, and includes educational sessions on new treatments, therapies, and trends, and their application in patient care. The conference also provides a venue for education around best practices for cancer care delivery.

Click here to view the agenda for Clinical Updates in Oncology.

Click here to view the agenda for Operational Excellence in Cancer Care

Target Audience

This program is designed to meet the educational needs of physicians/oncologists, nurse practitioners, nurses, physician associates, pharmacists, and other health care professionals who manage patients with cancer. 

Learning Objectives

The goal of the NCCN 2026 Annual Conference is to ensure that members of the interprofessional oncology care team have the knowledge and skills necessary to:

  • Apply the current recommendations for oncology and key updates in the NCCN Guidelines® to optimize the management of patients with cancer. 
  • Evaluate new, emerging, and novel therapeutic agents, treatment strategies, and clinical trials data and apply relevant findings into the management of patients with cancer.
  • Communicate with members of the interprofessional oncology care team to improve collaborative performance in the management of patients with cancer and the delivery of oncology care. 

Click here to view the learning objectives for Clinical Updates in Oncology.

Click here to view the learning objectives for Operational Excellence in Cancer Care

Additional information
Supporters: 

This educational activity is supported by educational grants from:

  • AstraZeneca
  • Exact Sciences
  • Johnson & Johnson
  • Novartis
  • PharmaEssentia
  • Puma Biotechnology
  • Recordati Rare Diseases Inc.
  • Revolution Medicines
  • Sirtex

This educational activity is supported by independent medical education grants from:

  • AbbVie
  • ADC Therapeutics
  • GSK

Supported by independent educational grants from:

  • Blue Earth Diagnostics
  • Merck & Co., Inc., Rahway, NJ, USA

This activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

This educational activity is supported by a medical education grant from Exelixis, Inc.

This project has been made possible in part by a grant from Varian, a Siemens Healthineers company. 

Course summary
Available credit: 
  • 20.25 AAPA Category 1 CME credit
  • 20.25 AMA PRA Category 1 Credit™
  • 20.25 ANCC contact hours
    • 11.25 ANCC Pharmacology Contact Hours
  • 20.25 CCM clock hours
  • 20.25 Participation
Course opens: 
03/29/2026
Course expires: 
03/26/2027
Event starts: 
03/27/2026 - 8:00am EDT
Event ends: 
03/29/2026 - 11:00am EDT
Click here to view the faculty disclosures for this program.
 
NCCN Continuing Education Disclosure Policy 
It is the policy of NCCN that all planners, faculty, moderators, authors, reviewers and anyone involved in the planning and delivery of NCCN continuing education activities are expected to disclose ALL financial relationships they have had in the past 24 months with ineligible companies. 
 

The ACCME Standards for Integrity and Independence require that individuals who refuse to provide this information will be disqualified from involvement in the planning and implementation of accredited continuing education presented by NCCN. NCCN identifies, mitigates, and discloses to learners all relevant financial relationships.

In addition, all content has been reviewed to ensure education promotes safe, effective patient care and does not promote the products or services of an ineligible company. Content, including any presentation of therapeutic options, is fair, balanced, evidence-based, scientifically accurate, and free of commercial bias and marketing.

Definitions 

Ineligible Company: An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. 

Relevant Financial Relationships: Financial relationships of any dollar amount occurring within the past 24 months are defined as relevant if the educational content an individual can control is related to the business lines or products of an ineligible company. There is no minimum financial threshold. We ask for disclosure of ALL financial relationships with ineligible companies, regardless of the amount and regardless of the potential relevance of each relationship to the education.

Faculty Disclaimers

All faculty for this continuing education activity are competent in the subject matter and qualified by experience, training, and/or preparation for the tasks and methods of delivery.

Faculty presentations may include discussion of off-label use. Faculty will disclose that the use in question is not currently approved by the FDA per the product labeling or marketing. 

image
Joint Accreditation
In support of improving patient care, National Comprehensive Cancer Network (NCCN) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physicians
NCCN designates this live activity for a maximum of 20.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses
NCCN designates this educational activity for a maximum of 20.25 contact hours. This program offers up to 11.25 pharmacotherapeutic contact hours for nurses. 

Pharmacists

NCCN designates this knowledge-based continuing education activity for 20.25 contact hours (2.025 CEUs) of continuing education credit. UAN: JA4008196-0000-26-019-L01-P

Physician Associates
NCCN has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 20.25 AAPA Category 1 CME credit. PAs should only claim credit commensurate with the extent of their participation.

Case Managers
This program has been pre-approved by The Commission for Case Manager Certification to provide continuing education credit to CCM® board certified case managers. Credit approval for case managers is pending for this program.  

American Board of Internal Medicine Maintenance of Certification (MOC)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 20.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
 
Aggregated participant data will be shared with the commercial supporters of this activity.
American Board of Pathology Continuing Certification (CC)
This activity has been registered to offer credit in the American Board of Pathology’s (ABPath) Continuing Certification program. Participants may earn up to 20.25 Lifelong Learning (Part II) credits.
 
Aggregated participant data will be shared with the commercial supporters of this activity.
American Board of Surgery Continuous Certification (CC)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME requirements of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

American Board of Medical Specialties Maintenance of Certification (MOC)
Through the American Board of Medical Specialties (“ABMS”) ongoing commitment to increase access to practice relevant Continuing Certification Activities through the ABMS Continuing Certification Directory, the NCCN 2026 Annual Conference has met the requirements as a Lifelong Learning CME Activity (apply toward general CME requirement) by the following ABMS Member Boards:

Lifelong Learning CME Activity
Colon and Rectal Surgery
Medical Genetics and Genomics
Radiology
Urology

Permission to Upload Credits

For ABIM, ABPath, and ABS MOC points, your information will be shared with your board through NCCN's Joint Accreditation Program and Activity Reporting System (JA-PARS). Please allow 6-8 weeks for your MOC points to appear on your board records.

By sharing your Diplomate Board ID # and DOB, you are giving NCCN permission to use this information/data to report your participation to these boards via JA-PARS.

Available Credit

  • 20.25 AAPA Category 1 CME credit
  • 20.25 AMA PRA Category 1 Credit™
  • 20.25 ANCC contact hours
    • 11.25 ANCC Pharmacology Contact Hours
  • 20.25 CCM clock hours
  • 20.25 Participation
Please login or register to take this course.

Click the Take Course button to start the credit claiming process. You must be logged in with the email address used for registration.

CE/MOC credit should be claimed for the conference as a whole, not session by session. You may claim credit for the conference only one time. When calculating your total credits, you should take into account all of the sessions you viewed either live or via recording. (Please note that you have access to all of the session recordings until early June.) 

Pharmacists: you must complete all requirements for credit by Thursday, May 14, 2026.

Tracking Your Session Attendance: Click here to help keep track of your session attendance. This worksheet is for your reference only and should not be returned to NCCN staff. Completion of these worksheets is not required to claim continuing education credit.

Required Hardware/software

To complete this activity, users will need:

  • A device with an Internet connection
  • Adobe Reader or other PDF reader software for certificate viewing/printing